25/02/2026
Annual SWENOTECA meeting Thursday April 16th, at Gardermoen
Annual meeting april 16th Annual Meeting Thursday April 16th
A non profit Norwegain and Swedish organization commited to providing patients with testicular cance
25/02/2026
Annual SWENOTECA meeting Thursday April 16th, at Gardermoen
Annual meeting april 16th Annual Meeting Thursday April 16th
05/12/2025
Congratulations to Anna Thor from SWENOTECA for being awarded a SEK 100,000 grant! Her groundbreaking research focuses on improving care for men with testicular cancer and could pave the way for new treatment options. Read more about her inspiring work at https://wix.to/M1OxIJz
Congratulations Anna Thor from SWENOTECA awarded grant to improve care for men with testicular cancerAt the annual meeting of the Swedish Association for Urological Oncology (SFUO) in Stockholm on 13 November 2025, researcher Anna Thor from Karolinska Institutet received a SEK 100,000 grant — awarded in collabora...
13/02/2025
We had a successful Annual Meeting at the new Karolinska Hospital in Stockholm! Discover all the major insights and highlights. Don't miss out! Read more here: https://wix.to/h5RRere
Protocol from Annual Meeting 2025 Thursday, February 6th, this year's annual meeting was arranged at the new Karolinska Hospital, Solna in Stockholm. We would like to thank all speakers and participants for making this a memorable and educational day. Congratulations to Dr. Anna Thor on the excellent public defense of her PhD disser...
02/12/2024
New version on SWENOTECA X have now been published. Along with the new update, new patient informations for all patients are also avaliable.
Update SWENOTECA X A revision of the SWENOTECA X protocol and new patients information have now been published. The main change is regarding stage I seminoma patients with risk factors (stromal invation in rete te**is or/and tumor over 4 cm). For this patient group surveillance or adjuvant carboplatin are now equal op...
02/12/2024
Invitation to SWENOTECA Annual Meeting 2025.
Stockholm, Thursday February 6th.
New Blog Post Annual Meeting February 6th, 2025
13/09/2024
Save the date. Next Annual Meeting in Stockholm, February 6th, 2025. https://wix.to/v8EYU06
Annual meeting, save the date Dear friends, the next annual meeting will take place in Stockholm on Thursday, February 6th, 2025. Detailed invitations and program will be sent out in November.
25/04/2024
ABC-study fully included. https://wix.to/14bVfAt
ABC-study is now closed for inclusion The ABC-study has now fully included. From April 25th we close the study for inclusion. A great thanks to all patiebts and personell involved in the inclusion of the patients. The study will continue with clinical follow-up and quality of life registrations for a total of ten years.
07/12/2023
📣 New guidelines for follow-up and protocol from our annual meeting! Check them out at www.swenoteca.org
24/09/2022
The last few weeks have been different. But I'm able to say weeks and not months because of great medical help, a little luck and a good decision. Very grateful for the public healthcare system in Norway. Thank you! But it's that good first decision that I want to talk about now.
I felt a change in my body. I wasn't sure what it was, or if it was anything at all. But I decided to have it checked out. I went to see a doctor, and was quickly transfered to the hospital where they confirmed what the doctor suspected. Testicle cancer.
Tests, scans and surgery all happened very quickly. And already after the first week I knew the prognoses looked very good. All thanks to that first decision to go see a doctor as soon as I suspected something was off.
Did you know that testicle cancer is the most common type of cancer for men under 50? And that it's not uncommon that the patients are as young as their early 20s. I didn't know, but now I do.
What I also know is that men are not great at talking about health issues. And sometimes that's exactly what you need to do to get knowledge, or to make that good decision to go see a doctor.
If you live in Norway and you have any questions, you should reach out to Kreftforeningen They've got both experienced people and answers to questions you might have. They do a great job. And I'm sure other countries have similar foundations.👍
Kjære Aksel Lund Svindal. Takk for din åpenhet om testikkelkreft. Vi anbefaler alle menn å regelmessig undersøke testiklene sine og kontakte fastlege hvis en testikkel forandrer størrelse, får en kul eller blir hard. SWENOTECA har siden 1981 jobbet for at norske og svenske menn med testikkelkreft skal få den best mulige behandlingen for sin sykdom. Som et resultat av dette har Norge og Sverige idag den beste overlevelse ved testikkelkreft i verden.
Dear Aksel Lund Svindal. Thank you for your openness about testicular cancer. We recommend that all men regularly examine their testicles and contact their GP if a testicle changes size, develops a lump or becomes hard. SWENOTECA has since 1981 worked for Norwegian and Swedish men with testicular cancer to receive the best possible treatment for their disease. As a result of this, Norway and Sweden today have the best testicular cancer survival rate in the world.
Kreftforeningen
22/06/2022
Dear friends. It is finally time to meet face to face again. See you in Tromsø in August.
Annual Meeting August 25-26, 2022 Dear SWENOTECA friends. It is finally time to meet face to face again. This time for the postponed 40-year anniversary meeting. The meeting will be arranged at Sommarøy Arctic Hotel, at the Sommarøy Island about an hour drive from Tromsø Airport. We have an exciting program with a particular focu...
15/04/2021
Dear SWENOTECA friends. Due to the COVID-situation, this years annual meeting must be postponed. Hope to see you in Tromsø next spring. Save the date.
Update: SWENOTECA Anniversary 2022 Dear SWENOTECA friends. Due to the COVID-situation, we must postpone the planned 40th anniversary. The meeting planned for Oct 14-15 will instead take place April 29-29. We would like to invite all current and former SWENOTECA friends to Tromsø for a 2-days celebration. More information will follow...